| ||||||||||||||
|
|
|||||||||||||

*Department of Anaesthesia, National University Hospital; and
Department of Anaesthesia and Surgical Intensive Care, Singapore General Hospital, Singapore
Address correspondence and reprints requests to Lian Kah Ti, MMed, Department of Anaesthesia, National University Hospital, 5 Lower Kent Ridge Rd., Singapore 119074, Republic of Singapore. Address e-mail to anatilk{at}nus.edu.sg
| Abstract |
|---|
|
|
|---|
Implications: In this randomized, controlled trial, we compared the ease of insertion of the laryngeal mask airway in adults after induction of anesthesia with either a sevoflurane vital capacity breath technique or propofol IV. We conclude that sevoflurane compares favorably with propofol, although prolonged jaw tightness may delay laryngeal mask airway insertion.
| Introduction |
|---|
|
|
|---|
Recently, single vital capacity breath (VCB) inhaled induction of anesthesia with sevoflurane has been used as an alternative to IV induction in adults. This method is rapid, with little excitatory phenomena, high patient acceptance, and good hemodynamic stability (3). Rapid insertion of the LMA after VCB induction may allow the use of sevoflurane as a single drug for the induction and maintenance of anesthesia, which would ease the transition period and lead to cost-savings (4). Therefore, in this study, we compared the reliability, quality, and speed of LMA insertion in adult patients after sevoflurane VCB inhaled induction and propofol IV induction of anesthesia.
| Methods |
|---|
|
|
|---|
20 cigarettes per day), and with impaired ability to communicate (e.g., confusion, poor hearing or language barrier) were excluded from the study. The patients were randomized by computer-generated numbers into two groups. Patients allocated to the sevoflurane group were taught the VCB technique. No patients were premedicated. For patients in the sevoflurane group, a circle CO2 absorber circuit with a 5-L reservoir bag was used. The circuit was primed with sevoflurane 8% in a 2:1 ratio of nitrous oxide to oxygen at a fresh gas flow of 6 L/min for 1 min. The patients were asked to take a deep breath then exhale to residual volume. The mask with the primed circuit was placed firmly over the patients face. The patients were then instructed to inhale a VCB and hold it as long as they could. The start of induction was taken as the point at which the patients completed their VCB. While holding their breath, the patients were asked to open their eyes every 10 s. Failure to do so was taken as loss of consciousness (LOC). This was confirmed by testing for the loss of eyelash reflex. Duration of vital capacity breath-hold was noted. Ninety seconds after the start of induction, the ease of mouth opening was assessed (possible or impossible). Ninety seconds was chosen because it represents the time at which all patients would have completed their VCB. If mouth opening was impossible, another attempt was made every 30 s up, to a maximum of four tries. An attempt to open the mouth was considered an attempt at insertion. During this time, anesthesia was maintained with sevoflurane at a dial concentration of 8% and nitrous oxide 67% in oxygen.
Once mouth opening was possible, insertion of the LMA was attempted, and the degree of attenuation of laryngeal reflexes was assessed. This was classified as full when the LMA was inserted smoothly; partial when insertion was accompanied by gagging, coughing or involuntary movement; or poor when LMA insertion was impossible. A size 3 or 4 LMA was used for patients weighing <70 kg or >70 kg, respectively, regardless of gender.
Patients in the propofol group breathed oxygen for 3 min and were anesthetized with propofol 3 mg/kg IV mixed with lidocaine 0.3 mg/kg, given over 30 s. Midway through induction (at 15 s), the patients were asked if they felt any pain from the injection. Time to LOC was determined as it had been for the sevoflurane group. Thirty seconds after the completion of propofol induction (i.e., 60 s after the start of the propofol injection), ease of mouth opening was assessed and, if possible, LMA insertion was attempted. If impossible, repeat attempts were made every 30 s up to a maximum of four attempts, each time preceded by propofol boluses of 0.5 mg/kg IV
LMA insertions were performed by the same investigator (LKT) using the technique recommended in the Intavent® LMA manual (Berkshire, UK). Once the LMA was inserted, all patients were given sevoflurane 4.0% in 67% nitrous oxide in oxygen at a fresh gas flow rate of 3 L/min for 3 min, before decreasing the dial concentration of sevoflurane to 2% for maintenance. Noninvasive blood pressure, electrocardiogram lead II, pulse oximeter, ETCO2, and end-tidal sevoflurane readings were recorded every minute for 5 min. Any failures of insertion, defined as failure to insert the laryngeal mask after four tries, were rescued with succinylcholine 25 mg IV. No controlled or assisted breaths were given unless the patient suffered oxygen desaturation to a pulse oximetry reading of <90%. The decision not to manually ventilate our patients between LMA insertion attempts was intended to avoid abolishing their hypercarbic drive, which would prolong the period of apnea.
An independent but nonblinded observer noted the presence of complications related to anesthetic induction and insertion of the LMA. These included involuntary movement (excitatory movement or withdrawal from pain of injection), coughing, gagging, apnea (when time to onset of spontaneous respiration after insertion of the laryngeal mask was >30 s) and laryngospasm. At the end of the operation, the LMAs were removed with the patients still anesthetized. The presence of blood on the mask, signifying trauma on insertion, was noted. Once fully awake, the patients were interviewed by a blinded investigator who asked whether they found the induction of anesthesia pleasant and whether they had a sore throat.
All results are expressed as mean ± SD or as group percentages. Students t-tests, with Bonferroni correction where appropriate, were used for the patients variables and hemodynamic changes.
2 tests, incorporating Fishers exact test where appropriate, were used for the variables of induction, quality of LMA insertion, complications, and postoperative assessment. A P value <0.05 was taken as statistically significant. Statistical calculations were performed using SPSS 8.0 (SPSS Inc., Chicago, IL).
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Anesthetic induction and LMA insertion using sevoflurane have several advantages. Sevoflurane allows a smoother transition to the maintenance phase without a period of apnea. Apnea (defined as failure to start spontaneous ventilation within 30 s of LMA insertion) occurred in 32% of the patients in the propofol group but did not occur in the sevoflurane group. The presence of apnea often requires the anesthesiologist to ventilate the patient manually while awaiting the return of spontaneous ventilation, therefore nullifying the benefit of freeing the anesthesiologists hands afforded by the LMA. Sevoflurane prevents the pain on injection associated with propofol. In this study, 31% of patients complained of pain during propofol induction despite the use of lidocaine. There was less hypotension with sevoflurane, although transient hypotension >20% of baseline was seen in individual patients from both groups.
In a related study, Muzi et al. (5) achieved insertion of LMA after sevoflurane induction after 1.7 min, compared with the time taken for LMA insertion in our sevoflurane group (127 s). The shorter time may be related to their use of the less reported triple breath technique, which is associated with a shorter time of induction (6). However, no comparison was made with other techniques. Hall et al. (7) compared LMA insertion using the single breath technique with sevoflurane 8% with that using IV propofol 3 mg/kg. They showed that the addition of nitrous oxide enhances the safety and speed of sevoflurane induction, but they did not compare the ease and quality of LMA insertion at the earliest opportunity. This resulted in relatively slow times for LMA insertion (109 and 146 s for the propofol and sevoflurane groups, respectively).
Our main difficulty regarding the quality of LMA insertion when using sevoflurane was initial difficulty in mouth opening. Interestingly, Muzi et al. (5) also reported jaw tightness after sevoflurane anesthetic induction, which resulted in failure to insert the LMA in several patients. Similarly, Hall et al. (7) reported longer time to jaw relaxation with sevoflurane compared with propofol, although they did not postulate any reasons for it. The likely explanation for the poor mouth opening in our patients is the lag time during which the alveolar concentration of sevoflurane equilibrates with the brain, which results in inadequate anesthesia during the initial attempt at insertion. This is supported by the fact that the LMA was eventually inserted in all patients. Furthermore, relaxation of the jaw muscles sufficient for a jaw thrust may be a reflection of adequate depth of anesthesia (8). However, Inomata and Nishikawa (9) dispute the importance of this lag time. They argue that this is unlikely to be important with sevoflurane because of its low blood-gas partition coefficient. In our patients, the end-tidal concentration of sevoflurane was 4.4% on release of the VCB, which translates into 2.45 minimum alveolar anesthetic concentration (MAC). This is adequate for LMA insertion because, although a MAC value for insertion of the LMA in adults is not known, it is likely to approximate 2.00%, the MAC value of sevoflurane for LMA insertion in children (10).
Another possible explanation for the difference in jaw relaxation between propofol and sevoflurane may be that the propofol group received more anesthetic, as equipotent doses of both drugs could not be determined. This may account for the greater number of patients with apnea in the propofol group. However, the dose of 3 mg/kg was not excessively large for the young unpremedicated patients we studied. A third possibility is related to the anesthetics themselves. Propofol is known to have a relaxant effect on jaw muscles (11), whereas inhaled anesthetics may cause increased muscle tone and spasticity (12). Therefore, for a similar depth of anesthesia, there may be greater jaw relaxation with propofol.
In contrast to the jaw tightness, there was excellent attenuation of laryngeal reflexes with both sevoflurane and propofol. This resulted in a low incidence of traumatic LMA insertions in our patients. Although LMA placement is more closely associated with deglutition and may only require suppression of the less sensitive hypopharynx for successful placement (13), stimulation of the anterior laryngeal structures may occur during insertion. Therefore, successful attenuation of the laryngeal reflexes was essential to reduce the incidence of respiratory complications during LMA insertions. This is not surprising for propofol, as it is known to depress laryngeal reflexes and facilitate LMA insertion (14). However, sevoflurane preserves laryngeal reflexes at values up to 1.8 MAC (15). Its effect on laryngeal reflexes above this value is unknown, but this study suggests that sevoflurane may depress laryngeal reflexes at the higher MAC values achieved in our patients.
The drawback of this study is that the depth of anesthesia between the two groups was not compared. However, it is difficult to compare the depth of anesthesia between inhaled and IV anesthetics. Although adequate depth of anesthesia may be correlated to plasma concentration for propofol (16), the correlation between MAC values and depth of anesthesia for sevoflurane is not clearly defined. This is because MAC refers to a state of equilibrium, which is not achieved during single VCB induction. Furthermore, the presence of a lag time between alveolar and brain concentrations may confound any attempted correlation. The use of electroencephalographic-related technology may provide some answers, as it has been shown to correlate with propofol-induced sedation (17). However, there is no correlation between sevoflurane anesthesia and adequate anesthesia to prevent movement using electroencephalographic derivatives (18). In addition, its reliability during single VCB induction has not been evaluated.
The cost of LMA insertion with sevoflurane was marginally less than with propofol. Using Dions equation (19), the cost of sevoflurane induction and the transition to maintenance as performed in this study, including the cost of priming the circuit, amounted to $12.17. The cost for the propofol group, including a 20-mL vial of propofol and the cost of sevoflurane during the transition to the maintenance phase, was $13.04.
We showed that the quality, safety, and reliability of sevoflurane single VCB induction of anesthesia makes it an alternative to IV propofol for the insertion of the LMA in adults. No adjuvant drugs were required. Sevoflurane VCB induction resulted in comparable complication rates and stable hemodynamic profile during the induction of anesthesia but a lower complication rate during LMA insertion. It produced a lower incidence of apnea and allowed a smoother transition to the maintenance phase. However, it may result in a longer time to LMA insertion due to prolonged jaw tightness.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. M Siddik-Sayyid, M. T. Aouad, S. K. Taha, D. G. Daaboul, P. G. Deeb, F. M. Massouh, M.-R. A. Muallem, and A. S. Baraka A Comparison of Sevoflurane-Propofol Versus Sevoflurane or Propofol for Laryngeal Mask Airway Insertion in Adults Anesth. Analg., April 1, 2005; 100(4): 1204 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kirkbride, J. L. Parker, G. D. Williams, and D. J. Buggy Induction of Anesthesia in the Elderly Ambulatory Patient: A Double-Blinded Comparison of Propofol and Sevoflurane Anesth. Analg., November 1, 2001; 93(5): 1185 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Joo and W. J. Perks Sevoflurane Versus Propofol for Anesthetic Induction: A Meta-Analysis Anesth. Analg., July 1, 2000; 91(1): 213 - 219. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|